PubMed · 15754724
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Carol McLoughlin. 2005. Nicotine replacement.. https://pubmed.ncbi.nlm.nih.gov/15754724/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
BACKGROUND: The need for effective treatment for pathological gambling is urgent. The majority of treatment studies and available treatments today are based upon cognitive-behavioural therapy. Recently, however, several studies investigating the effects of pharmacological interventions have been published. We conducted a review of these studies. MATERIAL AND METHODS: Studies for inclusion were identified through searches in PubMed covering the period 1950 to June 2005. A total of 12 studies were included. RESULTS: Selective serotonin reuptake inhibitors and similar compounds were associated with improvement in two out of five placebo-controlled studies and in two out of three studies with a pre-post design. Opioid antagonists were associated with improvement in one placebo-controlled study and in one study with a pre-post design. Mood stabilisers gave improvement in the one placebo-controlled study as well as in both studies with a pre-post design. INTERPRETATION: Pharmacotherapy may yield beneficial effects in the treatment of pathological gamblers. Still, more well-controlled studies with control of comorbid psychiatric conditions are needed.
Hyponatremia is a significant complication of treatment with serotonin selective reuptake inhibitors (SSRI). We describe a case of a 53-year-old woman that was started on fluoxetine 20 mg/day for depression. Nine days later, the patient started with weakness, nausea, progressing to confusion, inappetence and vomit. Three hours later she became unresponsive and had a generalized seizure. She was brought to our emergency service. On admission, the patient was normovolemic, without focal motor deficits, but had mild generalized muscle rigidity and Babinski's sign bilaterally. Serum sodium was 105 mmol/L, serum osmolality, 220 mmol/L, and urinary osmolality, 400 mmol/L. The other laboratory exams, chest X-ray, cerebrospinal fluid and cranium tomography were normal. She was found to have fluoxetine-induced SIADH and it was discontinued. We started the hyponatremia correction and, in 5 days, the mental status of the patient gradually returned to a normal baseline, paralleling the resolution of her hyponatremia, without recurrence. Hyponatremia and SIADH should be considered if a patient experiences deterioration in his or her clinical condition while taking SSRI. The use of SSRI antidepressants should be remembered in the differential diagnosis of drug-induced hyponatremia.